Early management of sepsis in medical patients in rural Thailand: a single-center prospective observational study

Kristina E Rudd, Viriya Hantrakun, Ranjani Somayaji, Suchart Booraphun, Chaiyaporn Boonsri, Annette L Fitzpatrick, Nicholas P J Day, Prapit Teparrukkul, Direk Limmathurotsakul, T Eoin West, Kristina E Rudd, Viriya Hantrakun, Ranjani Somayaji, Suchart Booraphun, Chaiyaporn Boonsri, Annette L Fitzpatrick, Nicholas P J Day, Prapit Teparrukkul, Direk Limmathurotsakul, T Eoin West

Abstract

Background: The burden of sepsis is highest in low- and middle-income countries, though the management of sepsis in these settings is poorly characterized. Therefore, the objective of this study was to assess the early management of sepsis in Thailand.

Methods: Pre-planned analysis of the Ubon-sepsis study, a single-center prospective cohort study of Thai adults admitted to the general medical wards and medical intensive care units (ICUs) of a regional referral hospital with community-acquired sepsis.

Results: Between March 2013 and January 2017, 3,716 patients with sepsis were enrolled. The median age was 59 years (IQR 44-72, range 18-101), 58% were male, and 88% were transferred from other hospitals. Eighty-six percent of patients (N = 3,206) were evaluated in the Emergency Department (ED), where median length of stay was less than 1 hour. Within the first day of admission, most patients (83%, N = 3,089) were admitted to the general medical wards, while 17% were admitted to the ICUs. Patients admitted to the ICUs had similar age, gender, and comorbidities, but had more organ dysfunction and were more likely to receive measured sepsis management interventions. Overall, 84% (N = 3,136) had blood cultures ordered and 89% (N = 3,308) received antibiotics within the first day of hospital admission. Among the 3,089 patients admitted to the general medical wards, 38% (N = 1,165) received an adrenergic agent, and 21% (N = 650) received invasive mechanical ventilation. Overall mortality at 28 days was 21% (765/3,716), and 28-day mortality in patients admitted to the ICUs was higher than that in patients admitted to the general medical wards within the first day (42% [263/627] vs. 16% [502/3,089], p < 0.001).

Conclusions: Sepsis in a regional referral hospital in rural Thailand, where some critical care resources are limited, is commonly managed on general medical wards despite high rates of respiratory failure and shock. Enhancing sepsis care in the ED and general wards, as well as improving access to ICUs, may be beneficial in reducing mortality.

Trial registration: The Ubon-sepsis study was registered on clinicaltrials.gov (NCT02217592).

Keywords: Critical care; Global health; Management; Sepsis; Thailand.

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

© The Author(s). 2019.

Figures

Fig. 1
Fig. 1
Kaplan-Meier curve demonstrating 28-day survival by admitting location

References

    1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:801–810. doi: 10.1001/jama.2016.0287.
    1. Fleischmann C, Scherag A, Adhikari NKJ, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis – current estimates and limitations. Am J Respir Crit Care Med. 2016;193:253–272. doi: 10.1164/rccm.201504-0781OC.
    1. Cheng AC, West TE, Limmathurotsakul D, Peacock SJ. Strategies to reduce mortality from bacterial sepsis in adults in developing countries. PLoS Med. 2008;5:1173–1179. doi: 10.1371/journal.pmed.0050175.
    1. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017;45:486–552. doi: 10.1097/CCM.0000000000002255.
    1. Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41:1167–1174. doi: 10.1097/CCM.0b013e31827c09f8.
    1. Kaukonen K-M, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311:1308–1316. doi: 10.1001/jama.2014.2637.
    1. The ARISE Investigators and the ANZICS Clinical Trials Group Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371:1496–1506. doi: 10.1056/NEJMoa1404380.
    1. Mouncey PR, Osborn TM, Power GS, Harrison D a, Sadique MZ, Grieve RD, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372:1301–1311. doi: 10.1056/NEJMoa1500896.
    1. The ProCESS Investigators A randomized trial of protocol-based care for early septic shock. Process trial. N Engl J Med. 2014;370:1–11. doi: 10.1056/NEJMoa1401602.
    1. Andrews B, Semler MW, Muchemwa L, Kelly P, Lakhi S, Heimburger DC, et al. Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: a randomized clinical trial. JAMA. 2017;318:1233–1240. doi: 10.1001/jama.2017.10913.
    1. Hantrakun V, Somayaji R, Teparrukkul P, Boonsri C, Rudd K, Day NPJ, et al. Clinical epidemiology and outcomes of community acquired infection and sepsis among hospitalized patients in a resource limited setting in Northeast Thailand: a prospective observational study (Ubon-sepsis) PLoS One. 2018;13:e0204509. doi: 10.1371/journal.pone.0204509.
    1. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165–228. doi: 10.1007/s00134-012-2769-8.
    1. Conde KAP, Silva E, Silva CO, Ferreira E, Freitas FGR, Castro I, et al. Differences in sepsis treatment and outcomes between public and private hospitals in Brazil: a multicenter observational study. PLoS One. 2013;8:e64790. doi: 10.1371/journal.pone.0064790.
    1. Teerawattanasook N, Tauran PM, Teparrukkul P, Wuthiekanun V, Dance DAB, Arif M, et al. Capacity and utilization of blood culture in two referral hospitals in Indonesia and Thailand. Am J Trop Med Hyg. 2017;97:1257–1261. doi: 10.4269/ajtmh.17-0193.
    1. Peltan ID, Mitchell KH, Rudd KE, Mann BA, Carlbom DJ, Hough CL, et al. Physician variation in time to antimicrobial treatment for septic patients presenting to the emergency department. Crit Care Med. 2017;45:1011–1018. doi: 10.1097/CCM.0000000000002436.
    1. Peltan ID, Brown SM, Bledsoe JR, Sorensen J, Samore MH, Allen TL, et al. Emergency department door-to-antibiotic time and long-term mortality in sepsis. Chest. 2019; Available from: . Accessed 1 May 2019.
    1. Zhang D, Micek ST, Kollef MH. Time to appropriate antibiotic therapy is an independent determinant of postinfection ICU and hospital lengths of stay in patients with sepsis. Crit Care Med. 2015:1–8 Available from: . Accessed 1 May 2019.
    1. Silva E, Pedro M, Sogayar A. Brazilian sepsis epidemiological study (BASES study) Crit Care Med. 2004;8:R251–R260.
    1. Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, et al. Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014. JAMA. 2017;318:1241. doi: 10.1001/jama.2017.13836.
    1. Southeast Asia Infectious Disease Clinical Research Network Causes and outcomes of sepsis in southeast Asia: a multinational multicentre cross-sectional study. Lancet Glob Health. 2017;5:e157–e167. doi: 10.1016/S2214-109X(17)30007-4.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi